Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13543371 | 0.88 | RAB9A (0.47) | RAB9ANPC1HPGDHCRTR1HCRTR2 | |
| SCHEMBL879552 | 0.86 | SMN1; SMN2 (0.43) | LMNAGAAHPGDTSHRSMN1; SMN2 | |
| SCHEMBL879518 | 0.80 | MAPT (0.50) | LMNAMAPTHPGDHCRTR1HCRTR2 | |
| SCHEMBL2736489 | 0.80 | ALDH1A1 (0.43) | RAB9ALMNAGAANPC1HPGD | |
| SCHEMBL13543373 | 0.79 | ACACB (0.36) | RAB9ALMNAGAANPC1MAPT | |
| SCHEMBL19483171 | 0.77 | FSCN1 (0.40) | RAB9ALMNAGAANPC1MAPT | |
| SCHEMBL10067205 | 0.76 | TSHR (0.49) | LMNAGAAMAPTHPGDTSHR | |
| SCHEMBL11814814 | 0.75 | RAB9A (0.44) | RAB9ALMNANPC1MAPTHPGD | |
| SCHEMBL12163930 | 0.74 | LMNA (0.53) | RAB9ALMNAGAANPC1MAPT | |
| SCHEMBL14963059 | 0.72 | LMNA (0.40) | LMNAGAAHPGDTSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9677053-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2017-06-13 | — | — | US | disclosed |
| US-20160237411-A1 | LACCASES FOR BIO-BLEACHING | VERENIUM CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-9353477-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2016-05-31 | — | — | US | disclosed |
| US-20150125936-A1 | LACCASES FOR BIO-BLEACHING | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| US-8951766-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2015-02-10 | — | — | US | disclosed |
| US-20130126110-A1 | LACCASES FOR BIO-BLEACHING | BASF SE (DE) | 2013-05-23 | — | — | US | disclosed |
| US-8377670-B2 | Laccases for bio-bleaching | VERENIUM CORPORATION (US) | 2013-02-19 | — | — | US | disclosed |
| US-20100018658-A1 | Laccases for Bio-Bleaching | VERENIUM CORPORATION (US) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100018658-A1 | Laccases for Bio-Bleaching | AOX1, GUSB, LPO | RAB9A 2542/4885LMNA 693/4885GAA 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.